What the results of Wegovy’s longest clinical trial yet show about ...
May 13, 2024 · New analyses of the longest clinical trial yet of the weight-loss drug Wegovy are shedding light on how quickly it helps people lose weight, how long they sustain that weight loss and how safe...
Zepbound sheds more weight than Wegovy in trial, Eli Lilly says - NBC News
Dec 4, 2024 · People who took Zepbound, Eli Lilly’s weight loss drug, shed more pounds than those on Novo Nordisk’s Wegovy in a head-to-head clinical trial, Lilly said in a news release Wednesday.
FDA Approves First Treatment to Reduce Risk of Serious Heart …
Today, the U.S. Food and Drug Administration approved a new indication for use for Wegovy (semaglutide) injection to reduce the risk of cardiovascular death, heart attack and stroke in adults...
At least 25,000 people in the US are starting weight-loss drug Wegovy …
May 2, 2024 · Drugmaker Novo Nordisk said it’s been increasing supply of its sought-after weight-loss drug Wegovy, with at least 25,000 people now starting to take the medicine each week in the United States....
Wegovy is a weight-loss drug. Health Canada says it can now be …
Nov 27, 2024 · Novo Nordisk said Wednesday that Wegovy is the first Health Canada-approved treatment for both chronic weight management and to reduce the risk of non-fatal myocardial infarction.
Wegovy approved to lessen heart attack, stroke risk in overweight ...
Mar 8, 2024 · The popular weight-loss drug Wegovy, which has helped millions of Americans shed pounds, can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in...
Novo Nordisk to increase supply of weight-loss drug Wegovy
Feb 1, 2024 · Novo Nordisk, maker of the popular weight-loss drug Wegovy, says it has started to increase the availability of the drug for people in the United States. Demand-driven supply shortages forced...
FDA approves Wegovy to reduce heart attack and stroke risk - NBC News
Mar 8, 2024 · The blockbuster weight loss drug Wegovy is now approved to reduce heart disease risk, drugmaker Novo Nordisk said Friday. The Food and Drug Administration has updated the drug's label, saying...
Wegovy Approved By FDA to Reduce Heart Attack Risk - The New York Times
Mar 11, 2024 · Wegovy, the blockbuster weight loss drug, is now approved for a new use: reducing the risk of heart attacks, strokes and cardiovascular-related death in adults who have heart disease and are...
Obesity drug Wegovy cut risk of serious heart ... - Associated Press News
Nov 11, 2023 · A new large study finds that the popular weight-loss drug Wegovy reduced the risk of serious heart problems by 20% in certain patients. The international trial showed the weekly injections prevented heart attacks, strokes and heart-related deaths.